Follow LinkedIn Looking for Oakley Capital?

Horizons Optical

Sector
Technology
Fund
Origin Fund
Year
2024
Location
Spain
Status
Current

Horizons Optical provides medical software used to make premium spectacle lenses.

Founded in Barcelona in 2017, Horizons’ proprietary and patented software is used by independent laboratories around the world to manufacture bespoke, ‘progressive’ lenses that can correct a range of eye conditions including short, mid and far sightedness as well as astigmatism, all in one lens.

Lenses manufactured using Horizons’ patented technology are positioned in the highest value-added segments of the optical industry, standing out for their distinctive qualities and outstanding optical performance. 10 million lenses were produced with Horizons’ technology in 2023. Horizons also provides equipment for opticians with the capability to scan consumers' faces and measure relevant facial parameters for the manufacturing of lenses and frames.

Oakley's Investment

Oakley’s investment in Horizons reflects its strategy of partnering with founder-led, entrepreneurial businesses to help them innovate and accelerate growth.  Oakley will leverage its strong track record of building market leaders to help Horizon accelerate its international growth plans, taking market share as a high-quality, innovative solution for lens manufacturers and opticians looking to offer bespoke eyecare solutions for consumers, while also leveraging its strong market reputation for exceptional customer service. Oakley will also support investment into R&D and Sales & Marketing to ensure Horizons continues to win as an innovator and disruptor in its core markets.

Quote Santiago Soler

Our focus on quality, innovation and exceptional customer care have driven Horizons’ strong performance to date. Oakley clearly shares our values and so we are delighted to be partnering with the Firm as we embark on the next stage of our expansion. We have travelled this path of growth alongside a strong partner in Sherpa Capital, to whom we are grateful not only for their investment in Horizons and belief in our potential but also for providing the company with a spirit of continuous improvement and excellence. We see enormous potential to further grow our international business, benefitting from Oakley’s expertise to expand our service offering and drive professional improvements across our business.

Santiago Soler

CEO — Horizons Optical

If you would like to know more, contact a member of the OCI team.

Back to top

Terms of Access Agreement and Disclaimers

Welcome to the website of Oakley Capital Investments Limited (“OCI”) of Rosebank Centre, 5th Floor, 11 Bermudiana Road, Pembroke, HM08, Bermuda.

Users of this website are responsible for observing all applicable laws and regulations in their relevant jurisdictions before proceeding to access the information contained within it. By proceeding to access the information, users are deemed to be representing and warranting that the applicable laws and regulations of their relevant jurisdiction allow them to do so.

If you are not permitted to view this website or are in any doubt as to whether you are permitted to view this website, please exit this website immediately by clicking on the button labelled “I Disagree” below.

Restrictions on accessing the website from certain countries

This website and its contents are only intended for persons in the UK and persons in any other jurisdiction to whom such information can lawfully be communicated without any authorisation, licence or approval being obtained. In particular, this website and its contents are not for release, publication or distribution, directly or indirectly, in whole or in part, in or into any member state of the European Economic Area, the United States, Canada, Australia, the Republic of South Africa or Japan. Viewing the information on this website may not be lawful in other jurisdictions.

The information on this website is not directed at and is not for use by any US Person (as defined in Regulation S under the US Securities Act of 1933 (as amended) (“US Securities Act”)). OCI has not been and will not be registered under the US Investment Company Act of 1940 (as amended) and, as such, holders of shares in OCI will not be entitled to the benefits of that Act. Shares in OCI have not been and will not be registered under the US Securities Act or with any securities regulatory authority of any state or other jurisdiction of the United States. Shares in OCI may not be offered, sold or delivered, directly or indirectly, in or into the United States or to, or for the account or benefit of, any US Person except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not require OCI to register under the US Investment Company Act of 1940 (as amended).

Shares in OCI have not been, and will not be, registered under the securities laws, or with any securities regulatory authority, of any jurisdiction outside the UK.

Purpose of the website

This website is for information only. It is not an offer or invitation to buy or sell, or a solicitation of an offer to buy or sell, or a recommendation to buy or sell, any securities mentioned. Nothing on this website should be taken as an invitation or inducement to engage in any investment activity. Information on this website does not, and should not be deemed to, constitute investment, tax, legal or any other advice.

Investment risk

All investment is subject to risk. The value of securities and any income from them may go down as well as up, and an investor may not get back the full amount of money invested. Past performance is not a reliable indicator or guarantee of future performance. There is no guarantee that the market price of OCI’s shares will fully reflect their underlying net asset value or that OCI’s investment objective will be achieved. You are strongly encouraged to seek individual advice from your professional adviser(s) before entering into any agreement to buy or sell any security or making any financial or investment decision.

Shares in OCI are traded on the Specialist Fund Segment of the main market of the London Stock Exchange and are intended for institutional, professional, professionally advised and knowledgeable investors primarily seeking exposure to private mid-market UK and Western European businesses through investment in the Oakley Capital Private Equity funds (or successor funds) and: (a) who understand and are willing to assume the potential risks of capital loss associated with investments in such companies, (b) who understand the illiquid nature of private equity compared to other asset classes, (c) for whom an investment in OCI’s shares would be of a long-term nature constituting part of a diversified portfolio, and (d) who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

OCI is not subject to the UK City Code on Takeover and Mergers.

Accuracy of information and availability of website

This website and its contents are made available on an “as is” and “as available” basis. OCI uses reasonable efforts to ensure that the information on this website is accurate, but OCI and its personnel and agents disclaim and exclude (to the fullest extent permitted by law) all warranties, representations or guarantees (whether express, implied or statutory) that the information is complete, accurate, up-to-date or suitable for a particular purpose. Actual outcomes or results may differ materially from those expressed or implied by any forecast. You agree that access to, and reliance on, this website and any information contained on it is entirely at your own risk.

General

The full terms governing your use of this website are available via the “Legal” link at the foot of each page of the website. If you proceed to access the website, please read the full terms carefully.

These terms of access (and any dispute, controversy, proceedings or claim of whatever nature arising out of or in any way relating thereto) shall be governed by English law. You agree that the courts of England shall have exclusive jurisdiction over any dispute arising out of or in connection with this website or these terms of access.

By clicking the “I accept” button below, you represent, warrant and agree that:

  1. you have read and understand the terms of access above and you agree to be bound by them;
  2. (if you are located outside the United Kingdom) the applicable laws and regulations of your jurisdiction allow you to access this website and the information contained within it; and
  3. you will not seek to acquire shares of OCI if you are a US Person except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not require OCI to register under the US Investment Company Act of 1940 (as amended).

If you cannot represent, warrant and agree to the above, you must click the button labelled “I disagree” or otherwise exit this website.

I agree
I disagree